Stellate Ganglion Block for Prevention of Post Mastectomy Depression
Recruiting · NCT06263907 · Interventional (participants receive a specific treatment) · Lead sponsor: Mansoura University
View the official record on ClinicalTrials.gov →Interventions studied
Stellate gangalion block
What this trial is about
Complications after mastectomy include chronic pain and depression.
Who can take part
Age range
21 Years to 65 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Female patients
- Age ranging from 18 to 65 years
- American Society of Anesthesiologists (ASA) no more than II
- Had unilateral cancer breast
- Scheduled to do unilateral modified radical mastectomy
Exclusion criteria
- Pregnant female
- Existing Horner syndrome
- Had any neuromuscular disease
- Had allergy to local anesthetics
- History of use of analgesics
- Had any deformity or a previous surgery in the neck or ipsilateral arm or breast
- Had any contraindication to the procedure (coagulation disorders, local infection, sepsis)
- Had any contraindication to the sympathetic blockade (decompensate cardiopulmonary or hemodynamic disorders)
- History of psychotic disorder including depression, bipolar disorder or personality disorder
- Patient with Beck Depression Inventory (BDI) score more than 13
Where it is running
1 location listed.
- Maha - Al Mansurah, Egypt